Phentermine works as a stimulant with cardiovascular concerns limiting long term use
Subgroup analyses revealed important differences based on comparator drugs: GLP-1RAs demonstrated greater effectiveness than SGLT2 inhibitors in preventing MALOs (IRR: 0.93, 95%CI: 0.87-0.99, P = 0.043), than DPP-4 inhibitors in preventing hepatic decompensation events (IRR: 0.74, 95%CI: 0.66-0.83, P = 0.003), and than insulin therapy in averting HCC development (IRR: 0.32, 95%CI: 0.13-0.80, P = 0.033) [64]
If you also use insulin, administer these medications at different injection sites
Nor was obesity their starting point
Peak Wellness is the better fit if you: are paying cash with no GLP-1 coverage want the lowest flat all-in price, $165 a month for semaglutide on the 6-month plan were denied by insurance or left another provider and want a fast, low-friction restart are comfortable with compounded medication from a 503A-credentialed pharmacy Ro is the better fit if you: have GLP-1 coverage through a large employer (5,000-plus staff) want FDA-approved medication only: the Wegovy pen, Wegovy HD, Zepbound, Ozempic, or Foundayo prefer a needle-free, evidence-backed oral option (Foundayo) put weight on peer-reviewed outcomes data and clinical infrastructure For a cortisol- or perimenopause-driven reader specifically, the molecule does the heavy lifting either way
doi: 10.1016/j.exger.2010.03.001 12